首页|口服益生菌在肝切除患者中应用效果的Meta分析

口服益生菌在肝切除患者中应用效果的Meta分析

扫码查看
目的 系统评价肝切除患者围手术期口服益生菌的应用效果。方法 计算机检索 PubMed、Cochrane Library、Web of Science、Embase、SinoMed、WanFangData、CNKI和VIP数据库,搜集肝切除患者围手术期口服益生菌疗效的随机对照试验(RCT),检索时限均从建库至2023年6月30日。由2名研究者独立筛选文献、提取数据并评价纳入研究的偏倚风险后,采用RevMan 5。4软件进行Meta分析。结果 最终纳入10个RCT,共715例患者。Meta分析结果显示,与安慰剂或空白对照相比,口服益生菌患者术后感染发生率[RR=0。60,95%CI(0。48,0。74),P<0。001]、血清内毒素水平[MD=-0。88,95%CI(-1。53,-0。22),P=0。009]、抗菌药物累积使用时间[MD=-1。48,95%CI(-2。17,-0。78),P<0。001]、天冬氨酸氨基转移酶水平[MD=-9。68,95%CI(-11。36,-8。01),P<0。001]、丙氨酸氨基转移酶水平[MD=-21。24,95%CI(-34。81,-7。68),P=0。002]、总胆红素水平[SMD=-0。70,95%CI(-0。95,-0。45),P<0。001]、C 反应蛋 白水平[SMD=-0。52,95%CI(-0。91,-0。13),P=0。009]、降钙素原水平[MD=-0。19,95%CI(-0。32,-0。05),P=0。006]、白细胞介素-6 水平[MD=-7。30,95%CI(-14。26,-0。33),P=0。04]及术后首次排气时间[MD=-1。16,95%CI(-1。51,-0。82),P<0。001]、住院时间[MD=-0。62,95%CI(-0。83,-0。41),P<0。001]、住院费用[SMD=-0。65,95%CI(-0。95,-0。34),P<0。001]等指标均较低。结论 当前证据显示,围手术期口服益生菌可显著降低肝切除患者术后感染率,减少炎症因子释放,促进术后肝功能及胃肠功能恢复,缩短住院时间及费用。受纳入研究数量和质量的限制,上述结论尚待更多高质量研究予以验证。
Effectiveness of oral probiotics for hepatectomised patients:a Meta-analysis
Objective To systematically review the effectiveness of perioperative oral probiotics in hepatic resection patients,and provide evidence-based clinical evidence.Methods PubMed,Cochrane Library,Web of Science,EMbase,SinoMed,WanFang Data,CNKI and VIP databases were electronically searched to collect randomized controlled trials(RCTs)on perioperative oral probiotics in hepatectomized patients from inception to June 30,2023.Two reviewers independently screened literature,extracted data and assessed the risk of bias of the included studies.Meta-analysis was performed by RevMan 5.4 software.Results A total of 10 RCTs were included,including 715 patients.The Meta-analysis showed that compared to placebo or blank controls,the incidence of postoperative infections in oral probiotic patients(RR=0.60,95%CI 0.48 to 0.74,P<0.001),serum endotoxin levels(MD=-0.88,95%CI-1.53 to-0.22,P=0.009),cumulative antibiotic use(MD=-1.48,95%CI-2.17 to-0.78,P<0.001),AST levels(MD=-9.68,95%CI-11.36 to-8.01,P<0.001),ALT levels(MD=-21.24,95%CI-34.81 to-7.68,P=0.002),TBiL levels(SMD=-0.70,95%CI-0.95 to-0.45,P<0.001),CRP levels(SMD=-0.52,95%CI-0.91 to-0.13,P=0.009),procalcitonin levels(MD=-0.19,95%CI-0.32 to-0.05,P=0.006),IL-6 levels(MD=-7.30,95%CI-14.26 to-0.33,P=0.04),and the first flatus time(MD=-1.16,95%CI-1.51 to-0.82,P<0.001),hospital stay(MD=-0.62,95%CI-0.83 to-0.41,P<0.001),hospitalisation costs(SMD=-0.65,95%CI-0.95 to-0.34,P<0.001)were lower.Conclusion Current evidence shows that perioperative oral probiotics can significantly reduce the postoperative infection rate and decrease the release of inflammatory factors in liver resection patients,promote the recovery of postoperative hepatic and gastrointestinal functions,and shorten the length of hospital stay and costs.Due to the limited quality and quantity of the included studies,more high quality studies are needed to verify the above conclusion.

ProbioticsHepatic resectionInfectionMeta-analysisSystematic reviewRandomized controlled trial

龚财芳、熊永福、赵俊宇、游川

展开 >

川北医学院附属医院肝胆外科(四川南充 637000)

川北医学院肝胆胰肠疾病研究所(四川南充 637000)

益生菌 肝切除 感染 Meta分析 系统评价 随机对照试验

国家自然科学基金青年科学基金

82003147

2024

药物流行病学杂志
中国药学会 武汉医药(集团)股份有限公司

药物流行病学杂志

CSTPCD
影响因子:0.746
ISSN:1005-0698
年,卷(期):2024.33(3)